전이성 전립선암 환자에서 발생된 2가지 형태의 응고병증
Two Different Coagulopathy Episodes in a Single Patient with Metastatic Prostate Cancer
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
We reported a case of two different episodes of critical coagulopathy in a single patient with metastatic prostate cancer (mPC). The patient initially visited the emergency room with a huge left retroperitoneal hematoma, high serum prostate-specific antigen level, and signs of acute disseminated intravenous coagulation (DIC) from mPC. With blood product replacement and anti-androgen therapy, the DIC-related symptoms and signs were relieved. During the follow-up, he was treated with docetaxel chemotherapy for hormone refractory PC. Four years later, he visited the emergency room again with relapsed coagulopathy and severe anemia that were not replaced with blood products. The laboratory findings were consistent with thrombotic thrombocytopenic purpura rather than DIC. A satisfactory recovery was achieved with a new cycle of docetaxel chemotherapy. Differentiation of the coagulopathies in PC is difficult; therefore, we describe the different features of two overlapping coagulopathies, which will be helpful in deciding on urgent treatment.
Abstract
We reported a case of two different episodes of critical coagulopathy in a single patient with metastatic prostate cancer (mPC). The patient initially visited the emergency room with a huge left retroperitoneal hematoma, high serum prostate-specific antigen level, and signs of acute disseminated intravenous coagulation (DIC) from mPC. With blood product replacement and anti-androgen therapy, the DIC-related symptoms and signs were relieved. During the follow-up, he was treated with docetaxel chemotherapy for hormone refractory PC. Four years later, he visited the emergency room again with relapsed coagulopathy and severe anemia that were not replaced with blood products. The laboratory findings were consistent with thrombotic thrombocytopenic purpura rather than DIC. A satisfactory recovery was achieved with a new cycle of docetaxel chemotherapy. Differentiation of the coagulopathies in PC is difficult; therefore, we describe the different features of two overlapping coagulopathies, which will be helpful in deciding on urgent treatment.
참고문헌 (9)
- de la Fouchardière C, "Coagulopathy in prostate cancer", Neth J Med, 61, pp.347~354 (2003)
- Doll DC, "Acute gastrointestinal bleeding as the presenting manifestation of prostate cancer", Cancer, 58, pp.1374~1377 (1986)
- Pinto F, "Disseminated intravascular coagulation secondary to metastatic prostate cancer: case report and review of the literature", Arch Ital Urol Androl, 81, pp.212~214 (2009)
- Park YA, "Platelet count and prothrombin time help distinguish thrombotic thrombocytopenic purpura-hemolytic uremic syndrome from disseminated intravascular coagulation in adults", Am J Clin Pathol, 133, pp.460~465 (2010)
- Caramello V, "Thrombotic thrombocytopenic purpura in advanced prostate cancer: case report and published work review", Int J Urol, 14, pp.150~152 (2007)
- Marcoullis G, "Microangiopathic hemolysis refractory to plasmapheresis responding to docetaxel and cisplatin: a case report", Med Oncol, 19, pp.189~192 (2002)
- Labelle CA, "Disseminated intravascular coagulation: treat the cause, not the lab values", Cleve Clin J Med, 72, pp.377~378 (2005)
- Rizzo C, "Thrombotic thrombocytopenic purpura: a review of the literature in the light of our experience with plasma exchange", Blood Transfus, 10, pp.521~532 (2012)
- Hyman DM, "Disseminated intravascular coagulation with excessive fibrinolysis in prostate cancer: a case series and review of the literature", Oncology, 81, pp.119~125 (2011)